The detection of a strong episignature for Chung–Jansen syndrome, partially overlapping with Börjeson–Forssman–Lehmann and White–Kernohan syndromes

Niels Vos,Sadegheh Haghshenas,Liselot van der Laan,Perle K. M. Russel,Kathleen Rooney,Michael A. Levy,Raissa Relator,Jennifer Kerkhof,Haley McConkey,Saskia M. Maas,Lisenka E. L. M. Vissers,Bert B. A. de Vries,Rolph Pfundt,Mariet W. Elting,Johanna M. van Hagen,Nienke E. Verbeek,Marjolijn C. J. Jongmans,Phillis Lakeman,Lynne Rumping,Danielle G. M. Bosch,Antonio Vitobello,Christel Thauvin-Robinet,Laurence Faivre,Sophie Nambot,Aurore Garde,Marjolaine Willems,David Genevieve,Gaël Nicolas,Tiffany Busa,Annick Toutain,Marion Gérard,Varoona Bizaoui,Bertrand Isidor,Giuseppe Merla,Maria Accadia,Charles E. Schwartz,Katrin Ounap,Mariëtte J. V. Hoffer,Marjan M. Nezarati,Marie-José H. van den Boogaard,Matthew L. Tedder,Curtis Rogers,Alfredo Brusco,Giovanni B. Ferrero,Marta Spodenkiewicz,Richard Sidlow,Alessandro Mussa,Slavica Trajkova,Emma McCann,Henry J. Mroczkowski,Sandra Jansen,Laura Donker-Kaat,Floor A. M. Duijkers,Kyra E. Stuurman,Marcel M. A. M. Mannens,Mariëlle Alders,Peter Henneman,Susan M. White,Bekim Sadikovic,Mieke M. van Haelst

DOI: https://doi.org/10.1007/s00439-024-02679-w

2024-05-25

Human Genetics

Abstract:Chung-Jansen syndrome is a neurodevelopmental disorder characterized by intellectual disability, behavioral problems, obesity and dysmorphic features. It is caused by pathogenic variants in the PHIP gene that encodes for the Pleckstrin homology domain-interacting protein, which is part of an epigenetic modifier protein complex. Therefore, we hypothesized that PHIP haploinsufficiency may impact genome-wide DNA methylation (DNAm). We assessed the DNAm profiles of affected individuals with pathogenic and likely pathogenic PHIP variants with Infinium Methylation EPIC arrays and report a specific and sensitive DNAm episignature biomarker for Chung–Jansen syndrome. In addition, we observed similarities between the methylation profile of Chung–Jansen syndrome and that of functionally related and clinically partially overlapping genetic disorders, White–Kernohan syndrome (caused by variants in DDB1 gene) and Börjeson–Forssman–Lehmann syndrome (caused by variants in PHF6 gene). Based on these observations we also proceeded to develop a common episignature biomarker for these disorders. These newly defined episignatures can be used as part of a multiclass episignature classifier for screening of affected individuals with rare disorders and interpretation of genetic variants of unknown clinical significance, and provide further insights into the common molecular pathophysiology of the clinically-related Chung–Jansen, Börjeson–Forssman–Lehmann and White–Kernohan syndromes.

genetics & heredity

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to develop a sensitive and specific biomarker for the diagnosis of Chung - Jansen syndrome and some of its functionally related and clinically partially overlapping genetic disorders (such as Börjeson - Forssman - Lehmann syndrome and White - Kernohan syndrome) by detecting the specific DNA methylation (DNAm) features (referred to as "epigenetic features" or "episignature") associated with Chung - Jansen syndrome. Specifically, the researchers hypothesized that pathogenic variants in the PHIP gene may lead to changes in genome - wide DNA methylation, thereby affecting epigenetic regulatory mechanisms. Therefore, they evaluated the DNA methylation profiles of individuals carrying pathogenic or likely pathogenic variants in the PHIP gene and reported a specific and sensitive DNAm epigenetic feature as a biomarker for Chung - Jansen syndrome. In addition, the study also observed similarities between the methylation profiles of Chung - Jansen syndrome and functionally related and clinically partially overlapping genetic disorders. Based on these observations, the researchers further developed a common epigenetic feature biomarker applicable to these disorders. This epigenetic feature can be part of a multi - class epigenetic feature classifier for screening affected individuals with rare disorders and interpreting genetic variants of unknown clinical significance, while providing further insights into the common molecular pathophysiology of these clinically relevant disorders.

The detection of a strong episignature for Chung–Jansen syndrome, partially overlapping with Börjeson–Forssman–Lehmann and White–Kernohan syndromes

DNA methylation episignature, extension of the clinical features and comparative epigenomic profiling of Hao-Fountain syndrome caused by variants in USP7 .

Diagnostic Utility of Genome-wide DNA Methylation Analysis in Genetically Unsolved Developmental and Epileptic Encephalopathies and Refinement of a CHD2 Episignature

Comprehensive EHMT1 variants analysis broadens genotype-phenotype associations and molecular mechanisms in Kleefstra syndrome

Diagnostic utility of DNA methylation analysis in genetically unsolved pediatric epilepsies and CHD2 episignature refinement

Diagnostic utility and reporting recommendations for clinical DNA methylation episignature testing in genetically undiagnosed rare diseases

Clinico-biological refinement of BCL11B-related disorder and identification of an episignature: A series of 20 unreported individuals

Epigenomic and phenotypic characterization of DEGCAGS syndrome

Truncating SRCAP variants outside the Floating-Harbor syndrome locus cause a distinct neurodevelopmental disorder with a specific DNA methylation signature

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Pathogenic variants in KMT2C result in a neurodevelopmental disorder distinct from Kleefstra and Kabuki syndromes

MSL2 variants lead to a neurodevelopmental syndrome with lack of coordination, epilepsy, specific dysmorphisms, and a distinct episignature

Further molecular and clinical delineation of co-locating 17p13.3 microdeletions and microduplications that show distinctive phenotypes

Delineating the molecular and phenotypic spectrum of the SETD1B-related syndrome

PhenoScore quantifies phenotypic variation for rare genetic diseases by combining facial analysis with other clinical features using a machine-learning framework

The clinical and molecular spectrum of the KDM6B-related neurodevelopmental disorder

Phenome-wide profiling identifies genotype-phenotype associations in Phelan-McDermid syndrome using family-sourced data from an international registry

Strong evidence for genotype-phenotype correlations in Phelan-McDermid syndrome: results from the developmental synaptopathies consortium

DNA methylation profiling in Kabuki syndrome: reclassification of germline KMT2D VUS and sensitivity in validating postzygotic mosaicism

Heterozygous ANKRD17 loss-of-function variants cause a syndrome with intellectual disability, speech delay, and dysmorphism